First case of focal epilepsy associated with SARS-coronavirus-2.
Acetaminophen
/ therapeutic use
Acetylcysteine
/ therapeutic use
Aged
Ambroxol
/ therapeutic use
Anticonvulsants
/ therapeutic use
COVID-19
/ complications
Cough
/ diagnosis
Dipyrone
/ therapeutic use
Epilepsies, Partial
/ complications
Female
Fever
/ diagnosis
Humans
Nasopharynx
/ virology
Radiography, Abdominal
SARS-CoV-2
/ pathogenicity
Treatment Outcome
COVID-19 Drug Treatment
COVID-19
case report
coronavirus
epilepsy
infection
outbreak
pandemic
Journal
Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
18
05
2020
revised:
27
05
2020
accepted:
28
05
2020
pubmed:
3
6
2020
medline:
30
12
2020
entrez:
3
6
2020
Statut:
ppublish
Résumé
A healthy patient presented to Klinikum Altmühlfranken Weißenburg Hospital, Germany, with two morning attacks of painful muscle spasm in the left upper and lower limbs, without altered consciousness. Full examinations, radiological imaging, electroencephalography, lumbar puncture, and autoimmune profile were either normal or not consistent with patient's complaint. Subsequent epileptic episodes were observed on admission day and the following days; thus, the patient was diagnosed with focal epilepsy. The patient started to develop a fever and severe cough on day 4, and SARS-coronavirus-2 was confirmed through a nasopharyngeal swap. She received anticonvulsants and symptomatic treatments and completely recovered. This report emphasizes the potential nervous system involvement in severe acute respiratory syndrome-coronavirus-2 pathogenesis.
Identifiants
pubmed: 32484990
doi: 10.1002/jmv.26113
pmc: PMC7300744
doi:
Substances chimiques
Anticonvulsants
0
Ambroxol
200168S0CL
Acetaminophen
362O9ITL9D
Dipyrone
6429L0L52Y
Acetylcysteine
WYQ7N0BPYC
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2238-2242Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
J Med Virol. 2020 Jul;92(7):786-790
pubmed: 32320066
Viruses. 2019 Dec 20;12(1):
pubmed: 31861926
Front Cell Neurosci. 2018 Oct 26;12:386
pubmed: 30416428
Neurologia (Engl Ed). 2018 Mar;33(2):71-77
pubmed: 27448521
J Exp Med. 2005 Aug 1;202(3):415-24
pubmed: 16043521
Future Virol. 2011 Nov;6(11):1339-1350
pubmed: 22267964
ACS Chem Neurosci. 2020 Apr 1;11(7):995-998
pubmed: 32167747
J Med Virol. 2020 Jul;92(7):699-702
pubmed: 32314810
J Virol. 2018 Aug 16;92(17):
pubmed: 29925652
SAGE Open Med Case Rep. 2019 Mar 21;7:2050313X19838750
pubmed: 30915222
J Clin Neurol. 2017 Jul;13(3):227-233
pubmed: 28748673
Influenza Other Respir Viruses. 2011 Sep;5(5):306-16
pubmed: 21668690
Lancet Neurol. 2020 May;19(5):383-384
pubmed: 32246917
Dev Med Child Neurol. 2011 Jul;53(7):600-9
pubmed: 21518343
JAMA Neurol. 2020 Jun 1;77(6):683-690
pubmed: 32275288
J Med Virol. 2020 Sep;92(9):1580-1586
pubmed: 32249956
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
J Med Virol. 2020 Jun;92(6):552-555
pubmed: 32104915
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
J Med Virol. 2020 Oct;92(10):2238-2242
pubmed: 32484990
J Med Virol. 2020 Oct;92(10):1782-1784
pubmed: 32293714
J Med Virol. 2020 Jun;92(6):602-611
pubmed: 32104911
N Engl J Med. 2017 Feb 9;376(6):584-594
pubmed: 28177862
J Med Virol. 2021 Feb;93(2):1193
pubmed: 32427357
Rev Med Virol. 2018 May;28(3):e1977
pubmed: 29664167
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Epilepsia. 2008 Jun;49(6):1066-74
pubmed: 18325012